German firm buys Corgenix

Corgenix Medical Corp. (OTCQB:CONX) agrees to be acquired by Mainz, Germany-based Orgentec Diagnostika for $16M ($0.27 per share) in cash.

Together, the firms will offer more than 350 diagnostic immunoassays, most based on ELISA (enzyme-linked immunosorbent assay).

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs